Skip to main content
. 2019 Dec 23;34(4):390–397. doi: 10.3803/EnM.2019.34.4.390

Table 2. Prevalence of Metabolic Syndrome in Men and Women According to GGT Quartile.

GGT, IU/L P for trend
Q1 Q2 Q3 Q4
Men Q1 (20≤) Q2 (21–29) Q3 (30–46) Q4 (≥47)
 Prevalence 2,061 (14.0) 3,435 (24.0) 4,546 (33.0) 6,264 (43.8) <0.001
 Model 1 Reference 1.988 (1.871–2.112) 3.136 (2.957–3.327) 5.043 (4.760–5.342)
 Model 2 Reference 2.027 (1.907–2.154) 3.251 (3.063–3.451) 5.320 (5.014–5.645)
 Model 3 Reference 1.534 (1.432–1.643) 1.939 (1.811–2.076) 2.754 (2.572–2.948)
Women Q1 (12≤) Q2 (13–16) Q3 (17–23) Q4 (≥24)
 Prevalence 3,392 (11.4) 5,233 (16.0) 7,640 (25.3) 10,495 (36.1) <0.001
 Model 1 Reference 1.387 (1.322–1.455) 2.329 (2.226–2.438) 3.867 (3.700–4.042)
 Model 2 Reference 1.395 (1.330–1.463) 2.354 (2.250–2.464) 3.934 (3.763–4.112)
 Model 3 Reference 1.155 (1.094–1.218) 1.528 (1.451–1.609) 2.022 (1.921–2.128)

Values are expressed as number (%) or adjusted odds ratio (95% confidence interval). Model 1: age-adjusted; Model 2: Model 1 plus adjustment for alcohol and smoking; Model 3: Model 2 plus adjustment for weight, blood pressure, and fasting plasma glucose.

GGT, gamma-glutamyltransferase.